Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis.

IF 3.4 2区医学 Q2 RHEUMATOLOGY

Journal of Rheumatology Pub Date : 2026-04-15 DOI:10.3899/jrheum.2025-0808.C1

Rebecca Fitzpatrick, Shadpour Demehri, Joseph Murray, Julie R Brahmer, Elena Ghotbi, Durrant Barasa, Clifton O Bingham, Ami A Shah, Laura C Cappelli

引用次数: 0

Abstract

J Rheumatol 2026; doi: 10.3899/jrheum.2025-0808In the originally published online version of this article, reference 8 was missing from the list of references. The missing reference has now been added: "8. Cunningham-Bussel A, Wang J, Prisco LC, et al. Predictors of rheumatic immune-related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancer. Arthritis Rheumatol 2022;74:527-40."This correction applies only to the February 1 2026 First Release. The complete list of references appears in the print and online issues.

查看原文本刊更多论文

评估髋关节骨关节炎作为免疫检查点抑制剂诱导的炎症性关节炎的危险因素。

[J]；doi: 10.3899 / jrheum。在本文最初发布的在线版本中，参考文献列表中缺少参考文献8。缺失的参考资料现在已被补充：王军，王建平，李建平，等。免疫检查点抑制剂治疗癌症后风湿性免疫相关不良事件和新发炎性关节炎的预测因素风湿关节炎，2022;74:527-40。此更正仅适用于2026年2月1日的第一次发布。完整的参考文献列表见于印刷版和网络版。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Rheumatology 医学-风湿病学

CiteScore

6.50

自引率

5.10%

发文量

285

审稿时长

1 months

期刊介绍： The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 41 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.